Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

Trial Identifier: RDEA594-501
Sponsor: Ardea Biosciences, Inc.
NCTID:: NCT02581553
Start Date: October 2015
Primary Completion Date: July 2016
Study Completion Date: August 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
USA, TX Austin, TX, USA, 78744